Clinical paperUsing extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: Treatment strategies and predictors of short-term and midterm survival☆
Introduction
Extracorporeal life support (ECLS) is an effective but short-term treatment for severe acute heart failure. Postcardiotomy ECLS may be necessary in order to bridge some adults with severe acute heart failure to recovery or heart transplantation (HT).1, 2, 3, 4 It is often difficult to predict the duration of ECLS support that will be necessary to achieve these endpoints.5, 6 The use of ECLS for this purpose is attractive due to its relative simplicity and inexpensiveness, and its ability to provide biventricular support. In general, 30% of adults supported with ECLS postoperatively are weaned from ECLS within 3–5 days.2, 4 Institutions that use ECLS as a rescue therapy for adults with refractory heart failure need clear treatment protocols with defined therapeutic targets. Within such a protocol, the strategy of ‘bridging to recovery’ can be altered to ‘bridge to transplant’ for those patients that fail to improve. In order to create such a protocol and to improve our clinical outcomes, we reviewed our experience over a 6-year period with adult postcardiotomy ECLS.
Section snippets
Materials and methods
Between January 2003 and June 2009, a total of 4180 patients underwent cardiac surgery in our institution. Of these patients, 114 patients required ECLS due to failure to be weaned from cardiopulmonary bypass (CPB) (n = 102) or a refractory cardiogenic shock after cardiac operation (n = 12). Only patients who received venoarterial ECLS for cardiac support (n = 110) were included in this retrospective study. Patients who received venovenous ECLS to treat postoperative pulmonary dysfunction (n = 4) were
Patient characteristics
The operations performed included: isolated coronary artery bypass grafting (CABG; n = 31), single valve surgery (n = 16), multiple valve procedures (n = 26), CABG combined with valve or left ventricular volume reduction surgery (n = 19), aortic root replacement with or without ascending aortic surgery (n = 8), postinfarction ventricular septal defect (n = 3), pulmonary endarterectomy (n = 4), and HT (n = 3). Sixty percent of the patients were successfully weaned from ECLS (67/110), and 41.8% (46/110) of them
Discussion
This study aimed to clarify the efficacy and limitations of postcardiotomy ECLS in adult patients. In the current study, nearly 50% of patients in this “crash and burn” category11 recovered after temporary ECLS support. However, postcardiotomy ECLS is inappropriate for patients with a high likelihood of irreversible cardiac damage unless consideration is given to bridging to HT. In this study, elective cardiac surgical patients with a preoperative LVEF < 30% that required postcardiotomy ECLS were
Limitations
The limitations of this study are the moderate number of study patients and its retrospective design. Refining surgical techniques and increasing experience with VADs and HT are necessary to improve our results. Further prospective research into postcardiotomy ECLS, both laboratory and clinical, are required to improve our therapeutic protocol.
Conclusion
Postcardiotomy ECLS is an effective but temporary measure. A comprehensive protocol that integrates VAD and HT is essential for institutions that apply ECLS as a rescue therapy for patients with severe acute heart failure. Monitoring after hospital discharge is also an important part of such a protocol, especially in patients with severe heart failure.
Conflict of interest statement
None to declare.
References (14)
- et al.
Application of “double bridge mechanical” resuscitation for profound cardiogenic shock leading to cardiac transplantation
Ann Thorac Surg
(2001) - et al.
Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock
Ann Thorac Surg
(2004) - et al.
Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years
J Thorac Cardiovasc Surg
(2001) - et al.
When to discontinue extracorporeal membrane oxygenation for postcardiotomy support
Ann Thorac Surg
(2001) - et al.
Impact of preexisting organ dysfunction on extracorporeal life support for non-postcardiotomy cardiopulmonary failure
Resuscitation
(2008) - et al.
Identifying neonates at a very high risk for mortality among children with congenital diaphragmatic hernia managed with extracorporeal membrane oxygenation
J Pediatr Surg
(2009) - et al.
Risk factor screening scale to optimize treatment for potential heart transplant candidates under extracorporeal membrane oxygenation
Am J Transplant
(2004)
Cited by (84)
Extracorporeal membrane oxygenation for postcardiotomy syndrome in adults
2022, Cardiopulmonary Bypass: Advances in Extracorporeal Life SupportContemporary Use of Venoarterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter RESCUE Registry
2021, Journal of Cardiac FailurePost Cardiotomy Extra Corporeal Membrane Oxygenation: Australian Cohort Review
2020, Heart Lung and CirculationPeripheral versus central extracorporeal membrane oxygenation for postcardiotomy shock: Multicenter registry, systematic review, and meta-analysis
2020, Journal of Thoracic and Cardiovascular Surgery
- ☆
A Spanish translated version of the abstract of this article appears as Appendix in the final online version at doi:10.1016/j.resuscitation.2010.04.031.